SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-055041
Filing Date
2024-04-30
Accepted
2024-04-30 17:26:58
Documents
19
Period of Report
2024-04-24
Items
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2413153d1_8k.htm   iXBRL 8-K 34612
2 EXHIBIT 99.1 tm2413153d1_ex99-1.htm EX-99.1 15198
3 EXHIBIT 99.2 tm2413153d1_ex99-2.htm EX-99.2 21521
8 GRAPHIC tm2413153d1_ex99-1img004.jpg GRAPHIC 15479
9 GRAPHIC tm2413153d1_ex99-2img005.jpg GRAPHIC 5661
10 GRAPHIC tm2413153d1_ex99-2img006.jpg GRAPHIC 38806
  Complete submission text file 0001104659-24-055041.txt   387643

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA nrxp-20240424.xsd EX-101.SCH 3245
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nrxp-20240424_def.xml EX-101.DEF 26897
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE nrxp-20240424_lab.xml EX-101.LAB 36508
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nrxp-20240424_pre.xml EX-101.PRE 25521
22 EXTRACTED XBRL INSTANCE DOCUMENT tm2413153d1_8k_htm.xml XML 5394
Mailing Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801
Business Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Filer) CIK: 0001719406 (see all company filings)

IRS No.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38302 | Film No.: 24898727
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)